AIM
JAZZ icon

Achmea Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Achmea Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,849
Closed -$353K – 568
2023
Q2 		$353K Hold
2,849
– – 0.01% 511
2023
Q1 		$417K Hold
2,849
– – 0.01% 475
2022
Q4 		$425K Sell
2,849
-886
-24% -$130K 0.01% 504
2022
Q3 		$498K Buy
+3,735
New +$568K 0.02% 486
2021
Q4 		– Sell
-172
Closed -$22K – 368
2021
Q3 		$22K Sell
172
-11,300
-99% -$1.71M ﹤0.01% 589
2021
Q2 		$2.04M Sell
11,472
-3,436
-23% -$595K 0.07% 318
2021
Q1 		$2.45M Sell
14,908
-833
-5% -$137K 0.09% 290
2020
Q4 		$2.6M Sell
15,741
-4,117
-21% -$613K 0.09% 258
2020
Q3 		$2.83M Sell
19,858
-16,845
-46% -$2.09M 0.12% 217
2020
Q2 		$4.05M Sell
36,703
-26,685
-42% -$2.95M 0.14% 142
2020
Q1 		$6.32M Buy
+63,388
New +$8.2M 0.29% 80
2018
Q3 		– Sell
-10,235
Closed -$1.76M – 487
2018
Q2 		$1.76M Hold
10,235
– – 0.06% 290
2018
Q1 		$1.54M Hold
10,235
– – 0.05% 333
2017
Q4 		$1.38M Buy
10,235
+3,004
+42% +$417K 0.05% 349
2017
Q3 		$1.06M Buy
7,231
+5,338
+282% +$807K 0.06% 320
2017
Q2 		$294K Hold
1,893
– – 0.02% 458
2017
Q1 		$275K Buy
+1,893
New +$247K 0.01% 480

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Achmea Investment Management's JAZZ Position: Q3 2023 in Review

Achmea Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 2,849 shares — an estimated $353K sold.

Achmea Investment Management first reported a position in JAZZ in Q1 2017 and held it in 17 quarters. The position peaked at $6.32M in Q1 2020. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Achmea Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Achmea Investment Management sold 2,849 Jazz Pharmaceuticals shares in Q3 2023, an estimated $353K.
  • Achmea Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 17 quarters.
  • Achmea Investment Management's Jazz Pharmaceuticals position peaked at $6.32M in Q1 2020.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Achmea Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.